Dovetail Genomics Signs Japan Distribution Agreement

SANTA CRUZ, Calif., Dec. 14, 2016 /PRNewswire/ -- Dovetail Genomics™ LLC, which offers accurate and highly contiguous genome assemblies to researchers and clinicians, today announced that it has entered into a distribution agreement with Tomy Digital Biology Co., Ltd. to bring Dovetail's genome assembly services to the Japanese market. The agreement gives Tomy exclusive rights to market and distribute Dovetail's genome assembly services to researchers in Japan.

"Japan is an important and expanding market in the area of genomic research, and we are eager to introduce Dovetail's services broadly in this region," said Dovetail CEO Todd Dickinson. "Tomy is a trusted name in the Japanese genomics market, giving us great confidence that our Japanese customers will receive outstanding customer support and seamless access to our genome assembly service."

"We are very excited to start a partnership with Dovetail Genomics," said Junichi Sunaga, Tomy's Vice President of Sales. "I believe many de novo assembly researchers in Japan will realize a huge benefit from the Chicago method Dovetail so successfully brought to market in the United States. This new service launch will result in many more de novo assemblies in Japan for a wide range of organisms."

Dovetail offers a la carte genome assembly services for plant, animal and microbial genomes. Customers can choose from a number of options for genome assembly including full de novo assembly (with Illumina or PacBio sequencing methods) or assembly improvement.

As one of Japan's most successful distributors of life science products from non-Japanese companies, Tomy offers a product lineup that extends from instruments through to software. Dovetail joins an impressive list of foreign companies, including PacBio, Biomatters and Ingenuity, whose products and services Tomy distributes in Japan.

About Dovetail Genomics
Dovetail Genomics LLC is transforming genomics by making long-range information readily accessible to all. The company enables researchers and clinicians to solve complex problems involving de novo assembly, structural variation, microbiome analysis, cancer research, phasing analysis and more by providing them a more comprehensive view of the genome. Its proprietary in vitro proximity ligation approach simplifies genomic discovery by integrating the highest quality long-range genomic information with next-gen sequencing output. Dovetail is based in Santa Cruz, California. For more information on Dovetail, its technology, and service offerings, visit dovetailgenomics.com. Follow Dovetail on Twitter @DTGenomics.

SOURCE Dovetail Genomics LLC

Related Links

http://dovetailgenomics.com